Lisata Therapeutics, Inc. (LSTA) vs Senti Biosciences, Inc. (SNTI)
A side-by-side comparison of Lisata Therapeutics, Inc. and Senti Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LSTA
Lisata Therapeutics, Inc.
$1.17HealthcareDelayed quote: Oct 6, 2026, 3:29 PM EDT
SNTI
Senti Biosciences, Inc.
$0.32HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
Total return — LSTA vs SNTI
growth of $100 · dividends reinvested · last 5yLSTA -94.3% (-43.6%/yr)SNTI -99.7% (-67.8%/yr)LSTA compounded faster over this window
Log scale — wide-divergence pair
LSTA SNTI
LSTA vs SNTI: by the numbers
- •LSTA is the larger company ($11M vs $10M market cap).
- •Both run net losses; LSTA's is the smaller (-14621.00% vs -90116.36% net margin).
Metrics side by side
Valuation
| Metric | LSTA | SNTI |
|---|---|---|
| P/S ratio | 106.54 | 182.06 |
| P/B ratio | 1.29 | N/A |
Profitability
| Metric | LSTA | SNTI |
|---|---|---|
| Gross margin | 14.12% | -16431.82% |
| Operating margin | -10711.18% | -289668.18% |
| Net margin | -14621.00% | -90116.36% |
| ROE | -177.35% | N/A |
| ROIC | -204.32% | -227.67% |
Growth (annualized)
| Metric | LSTA | SNTI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -43.85% |
| Total return CAGR (5Y) | -40.75% | -67.75% |
Frequently asked
- How have LSTA and SNTI total returns compared?
- Over the past 5 years, LSTA delivered -40.75% and SNTI delivered -67.75% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.